Thrivent Financial for Lutherans
IMGN

Thrivent Financial for Lutherans’s Immunogen Inc IMGN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-58,026
Closed -$383K – 2513
2021
Q2 		$383K Hold
58,026
– – ﹤0.01% 2262
2021
Q1 		$470K Sell
58,026
-7,490
-11% -$61.2K ﹤0.01% 2244
2020
Q4 		$423K Sell
65,516
-85,577
-57% -$499K ﹤0.01% 2193
2020
Q3 		$544K Sell
151,093
-136,611
-47% -$552K ﹤0.01% 1922
2020
Q2 		$1.32M Hold
287,704
– – ﹤0.01% 1312
2020
Q1 		$982K Buy
+287,704
New +$1.26M ﹤0.01% 1312

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans's IMGN Position: Q3 2021 in Review

Thrivent Financial for Lutherans sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 58,026 shares — an estimated $383K sold.

Thrivent Financial for Lutherans first reported a position in IMGN in Q1 2020 and held it in 6 quarters. The position peaked at $1.32M in Q2 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

  • Thrivent Financial for Lutherans reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 58,026 Immunogen Inc shares in Q3 2021, an estimated $383K.
  • Thrivent Financial for Lutherans first reported a position in Immunogen Inc in Q1 2020 and held it in 6 quarters.
  • Thrivent Financial for Lutherans's Immunogen Inc position peaked at $1.32M in Q2 2020.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2021, filed 15 Nov 2021.